Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Cash-to-Debt : 2.37 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Jiuzhou Pharmaceutical Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Zhejiang Jiuzhou Pharmaceutical Co's cash to debt ratio for the quarter that ended in Mar. 2024 was 2.37.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Zhejiang Jiuzhou Pharmaceutical Co could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Zhejiang Jiuzhou Pharmaceutical Co's Cash-to-Debt or its related term are showing as below:

SHSE:603456' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.3 Med: 2.26 Max: 20.04
Current: 2.37

During the past 13 years, Zhejiang Jiuzhou Pharmaceutical Co's highest Cash to Debt Ratio was 20.04. The lowest was 0.30. And the median was 2.26.

SHSE:603456's Cash-to-Debt is ranked better than
63.23% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs SHSE:603456: 2.37

Zhejiang Jiuzhou Pharmaceutical Co Cash-to-Debt Historical Data

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Zhejiang Jiuzhou Pharmaceutical Co Cash-to-Debt Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.65

0.38

1.63

3.12

7.72

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															5.20	4.06	3.90	7.72	2.37

Competitive Comparison of Zhejiang Jiuzhou Pharmaceutical Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jiuzhou Pharmaceutical Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Jiuzhou Pharmaceutical Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jiuzhou Pharmaceutical Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Zhejiang Jiuzhou Pharmaceutical Co's Cash-to-Debt falls into.

Zhejiang Jiuzhou Pharmaceutical Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Zhejiang Jiuzhou Pharmaceutical Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	3206.427	/	(14.543	+	400.945)
	=	7.72

Zhejiang Jiuzhou Pharmaceutical Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4059.468	/	(1305.484	+	409.793)
	=	2.37

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Zhejiang Jiuzhou Pharmaceutical Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Zhejiang Jiuzhou Pharmaceutical Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang, CHN, 318000

Website

http://www.jiuzhoupharma.com

Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Headlines

No Headlines